In vitro evaluation of heparin adsorption during haemoperfusion with dowex 1x2 anion exchange resin

M. Fini, G. Giavaresi, M. Spighi, R. Giardino, M. L. Florio

Research output: Contribution to journalArticle

Abstract

Haemoperfusion treatments have found clinical applications in various pathologies, even though problems due to the insufficient biocompatibility of sorbents have often limited its employment. Among these problems, there is that of heparin adsorption which can determine coagulation disorders or the necessity of a dosage correction during the extra corporeal circulation. The aim of the study was to test the influence of different methods of coating on heparin adsorption from an anion exchange resin coated with poly-hydroxyethyl-methacrylate. Eight haemoperfusion cartridges were prepared using 8 g of resin for each (4 cartridges contained resin coated by spray-coating technique and 4 coated by phase-separation one). Haemoperfusion was performed by using 600 IU of heparin (25,000 IU) corresponding to 0.12 ml in 500 ml of swine blood and a closed circuit. Blood flow rate was maintained at 15 ml/min and the circuit pressure was 70 torr during haemoperfusion. Blood samples were withdrawn at timed intervals before and after the column in order to evaluate blood heparin levels. The results demonstrated the superiority of the phase-separation technique that does not permit any interactions between adsorbent substance and drug. As a result of this, the adjustment of the dosage may not be necessary during further in vivo experiments.

Original languageEnglish
Pages (from-to)101-108
Number of pages8
JournalArtificial Cells, Blood Substitutes, and Immobilization Biotechnology
Volume23
Issue number1
Publication statusPublished - 1995

Fingerprint

Anion Exchange Resins
Hemoperfusion
Adsorption
Heparin
Ion exchange
Blood
Negative ions
Resins
Phase separation
Coating techniques
Networks (circuits)
Pathology
Sorbents
Coagulation
Biocompatibility
Adsorbents
Swine
Flow rate
Pressure
Coatings

Keywords

  • Haemoperfusion
  • Heparin
  • Resin

ASJC Scopus subject areas

  • Biotechnology
  • Biomedical Engineering
  • Biomaterials
  • Hematology

Cite this

In vitro evaluation of heparin adsorption during haemoperfusion with dowex 1x2 anion exchange resin. / Fini, M.; Giavaresi, G.; Spighi, M.; Giardino, R.; Florio, M. L.

In: Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, Vol. 23, No. 1, 1995, p. 101-108.

Research output: Contribution to journalArticle

@article{d8b77d3bde224a12bbca38fe73ec783c,
title = "In vitro evaluation of heparin adsorption during haemoperfusion with dowex 1x2 anion exchange resin",
abstract = "Haemoperfusion treatments have found clinical applications in various pathologies, even though problems due to the insufficient biocompatibility of sorbents have often limited its employment. Among these problems, there is that of heparin adsorption which can determine coagulation disorders or the necessity of a dosage correction during the extra corporeal circulation. The aim of the study was to test the influence of different methods of coating on heparin adsorption from an anion exchange resin coated with poly-hydroxyethyl-methacrylate. Eight haemoperfusion cartridges were prepared using 8 g of resin for each (4 cartridges contained resin coated by spray-coating technique and 4 coated by phase-separation one). Haemoperfusion was performed by using 600 IU of heparin (25,000 IU) corresponding to 0.12 ml in 500 ml of swine blood and a closed circuit. Blood flow rate was maintained at 15 ml/min and the circuit pressure was 70 torr during haemoperfusion. Blood samples were withdrawn at timed intervals before and after the column in order to evaluate blood heparin levels. The results demonstrated the superiority of the phase-separation technique that does not permit any interactions between adsorbent substance and drug. As a result of this, the adjustment of the dosage may not be necessary during further in vivo experiments.",
keywords = "Haemoperfusion, Heparin, Resin",
author = "M. Fini and G. Giavaresi and M. Spighi and R. Giardino and Florio, {M. L.}",
year = "1995",
language = "English",
volume = "23",
pages = "101--108",
journal = "Artificial Cells, Blood Substitutes, and Immobilization Biotechnology",
issn = "1073-1199",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - In vitro evaluation of heparin adsorption during haemoperfusion with dowex 1x2 anion exchange resin

AU - Fini, M.

AU - Giavaresi, G.

AU - Spighi, M.

AU - Giardino, R.

AU - Florio, M. L.

PY - 1995

Y1 - 1995

N2 - Haemoperfusion treatments have found clinical applications in various pathologies, even though problems due to the insufficient biocompatibility of sorbents have often limited its employment. Among these problems, there is that of heparin adsorption which can determine coagulation disorders or the necessity of a dosage correction during the extra corporeal circulation. The aim of the study was to test the influence of different methods of coating on heparin adsorption from an anion exchange resin coated with poly-hydroxyethyl-methacrylate. Eight haemoperfusion cartridges were prepared using 8 g of resin for each (4 cartridges contained resin coated by spray-coating technique and 4 coated by phase-separation one). Haemoperfusion was performed by using 600 IU of heparin (25,000 IU) corresponding to 0.12 ml in 500 ml of swine blood and a closed circuit. Blood flow rate was maintained at 15 ml/min and the circuit pressure was 70 torr during haemoperfusion. Blood samples were withdrawn at timed intervals before and after the column in order to evaluate blood heparin levels. The results demonstrated the superiority of the phase-separation technique that does not permit any interactions between adsorbent substance and drug. As a result of this, the adjustment of the dosage may not be necessary during further in vivo experiments.

AB - Haemoperfusion treatments have found clinical applications in various pathologies, even though problems due to the insufficient biocompatibility of sorbents have often limited its employment. Among these problems, there is that of heparin adsorption which can determine coagulation disorders or the necessity of a dosage correction during the extra corporeal circulation. The aim of the study was to test the influence of different methods of coating on heparin adsorption from an anion exchange resin coated with poly-hydroxyethyl-methacrylate. Eight haemoperfusion cartridges were prepared using 8 g of resin for each (4 cartridges contained resin coated by spray-coating technique and 4 coated by phase-separation one). Haemoperfusion was performed by using 600 IU of heparin (25,000 IU) corresponding to 0.12 ml in 500 ml of swine blood and a closed circuit. Blood flow rate was maintained at 15 ml/min and the circuit pressure was 70 torr during haemoperfusion. Blood samples were withdrawn at timed intervals before and after the column in order to evaluate blood heparin levels. The results demonstrated the superiority of the phase-separation technique that does not permit any interactions between adsorbent substance and drug. As a result of this, the adjustment of the dosage may not be necessary during further in vivo experiments.

KW - Haemoperfusion

KW - Heparin

KW - Resin

UR - http://www.scopus.com/inward/record.url?scp=0028796548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028796548&partnerID=8YFLogxK

M3 - Article

C2 - 7719441

AN - SCOPUS:0028796548

VL - 23

SP - 101

EP - 108

JO - Artificial Cells, Blood Substitutes, and Immobilization Biotechnology

JF - Artificial Cells, Blood Substitutes, and Immobilization Biotechnology

SN - 1073-1199

IS - 1

ER -